Paper36978303
Challenges of Colistin Use in ICU and Therapeutic Drug Monitoring: A Literature Review.
Rychlíčková J and 3 others. Antibiotics (Basel), 2023. Cited by 30 papers, by iCite.
Cite this record
ConductScience Library. Challenges of Colistin Use in ICU and Therapeutic Drug Monitoring: A Literature Review. Papers, record 36978303. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36978303
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| CZECRIN (LM2018128) | Ministry of Education, Youth and Sports Czech Republic | PubMed |
Source PubMed
References87
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25267662 | New colistin population pharmacokinetic data in critically ill patients suggesting an alternative loading dose rationale. | Antimicrob Agents Chemother | 2014 | https://conductscience.org/library/papers/25267662 | PubMed |
| 2 | 28680633 | Therapeutic drug monitoring for colistin therapy in severe multi-resistant Acinetobacter intracerebral abscess: A single case study with high-dose colistin and review of literature. | SAGE Open Med Case Rep | 2017 | https://conductscience.org/library/papers/28680633 | PubMed |
| 3 | 16723551 | Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa. | Antimicrob Agents Chemother | 2006 | https://conductscience.org/library/papers/16723551 | PubMed |
| 4 | 18606838 | Stability of colistin methanesulfonate in pharmaceutical products and solutions for administration to patients. | Antimicrob Agents Chemother | 2008 | https://conductscience.org/library/papers/18606838 | PubMed |
| 5 | 16503447 | Polymyxins: old antibiotics are back. | Lancet | 2006 | https://conductscience.org/library/papers/16503447 | PubMed |
| 6 | 28893773 | Colistin Is Extensively Lost during Standard In Vitro Experimental Conditions. | Antimicrob Agents Chemother | 2017 | https://conductscience.org/library/papers/28893773 | PubMed |
| 7 | 25267660 | Comparison of intrapulmonary and systemic pharmacokinetics of colistin methanesulfonate (CMS) and colistin after aerosol delivery and intravenous administration of CMS in critically ill patients. | Antimicrob Agents Chemother | 2014 | https://conductscience.org/library/papers/25267660 | PubMed |
| 8 | 35722356 | Plasma concentrations of Colistin sulfate in a patient with septic shock on extracorporeal membrane oxygenation and continuous renal replacement therapy: a case report. | Ann Transl Med | 2022 | https://conductscience.org/library/papers/35722356 | PubMed |
| 9 | 35028178 | An LC-MS/MS method for simultaneous analysis of the cystic fibrosis therapeutic drugs colistin, ivacaftor and ciprofloxacin. | J Pharm Anal | 2021 | https://conductscience.org/library/papers/35028178 | PubMed |
| 10 | 31660388 | Estimating the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in the United States Using Antibiotic Prescription Data. | Open Forum Infect Dis | 2019 | https://conductscience.org/library/papers/31660388 | PubMed |
| 11 | 28011614 | Dosing guidance for intravenous colistin in critically-ill patients. | Clin Infect Dis | 2017 | https://conductscience.org/library/papers/28011614 | PubMed |
| 12 | 27418577 | Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. | Clin Infect Dis | 2016 | https://conductscience.org/library/papers/27418577 | PubMed |
| 13 | 21555763 | Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients. | Antimicrob Agents Chemother | 2011 | https://conductscience.org/library/papers/21555763 | PubMed |
| 14 | 30151222 | Rapid, simple, and clinically applicable high-performance liquid chromatography method for clinical determination of plasma colistin concentrations. | J Pharm Health Care Sci | 2018 | https://conductscience.org/library/papers/30151222 | PubMed |
| 15 | 28335481 | Genetic Variants Contributing to Colistin Cytotoxicity: Identification of TGIF1 and HOXD10 Using a Population Genomics Approach. | Int J Mol Sci | 2017 | https://conductscience.org/library/papers/28335481 | PubMed |
| 16 | 23147733 | Colistin methanesulfonate and colistin pharmacokinetics in critically ill patients receiving continuous venovenous hemodiafiltration. | Antimicrob Agents Chemother | 2013 | https://conductscience.org/library/papers/23147733 | PubMed |
| 17 | 32052041 | Clinical and Laboratory Standards Institute and European Committee on Antimicrobial Susceptibility Testing Position Statements on Polymyxin B and Colistin Clinical Breakpoints. | Clin Infect Dis | 2020 | https://conductscience.org/library/papers/32052041 | PubMed |
| 18 | 25441071 | High-throughput hydrophilic interaction chromatography coupled to tandem mass spectrometry for the optimized quantification of the anti-Gram-negatives antibiotic colistin A/B and its pro-drug colistimethate. | J Chromatogr A | 2014 | https://conductscience.org/library/papers/25441071 | PubMed |
| 19 | 26369974 | Colistin Population Pharmacokinetics after Application of a Loading Dose of 9 MU Colistin Methanesulfonate in Critically Ill Patients. | Antimicrob Agents Chemother | 2015 | https://conductscience.org/library/papers/26369974 | PubMed |
| 20 | 21114395 | Resurgence of colistin: a review of resistance, toxicity, pharmacodynamics, and dosing. | Pharmacotherapy | 2010 | https://conductscience.org/library/papers/21114395 | PubMed |
Cited by23
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42404768 | Analysis of the efficacy and safety of intravenous injection combined with nebulized inhalation of polymyxin E sodium methanesulfonate in the treatment of carbapenem resistant gram-negative bacterial infections in the lungs. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42404768 | PubMed |
| 42183845 | Synergistic strategies to rescue the last-resort antibiotic colistin. | Arch Microbiol | 2026 | https://conductscience.org/library/papers/42183845 | PubMed |
| 41884470 | Efficacy and Safety of Different Colistin Administration Routes for Nosocomial Pneumonia Caused by Carbapenem-Resistant Organisms: A Single Centre, Open Label, Prospective Cohort Study. | Drug Des Devel Ther | 2026 | https://conductscience.org/library/papers/41884470 | PubMed |
| 41636946 | Stability of Colistin Active Forms in Biological Matrices: Effect of Temperature and Time. | Eur J Drug Metab Pharmacokinet | 2026 | https://conductscience.org/library/papers/41636946 | PubMed |
| 41258612 | Aztreonam-Avibactam: A Review in the Treatment of Serious Bacterial Infections Caused by Aerobic Gram-Negative Organisms. | Drugs | 2026 | https://conductscience.org/library/papers/41258612 | PubMed |
| 40629991 | Liquid chromatography-tandem mass spectrometry methods for clinical quantitation of antibiotics. | Bioanalysis | 2025 | https://conductscience.org/library/papers/40629991 | PubMed |
| 40458932 | Therapeutic Drug Monitoring of Amikacin and Colistin in Patients with Multidrug-Resistant Gram-Negative Infections Using a Portable Plasmonic Biosensor. | Anal Chem | 2025 | https://conductscience.org/library/papers/40458932 | PubMed |
| 40426572 | One Health at Risk: Plasmid-Mediated Spread of mcr-1 Across Clinical, Agricultural, and Environmental Ecosystems. | Antibiotics (Basel) | 2025 | https://conductscience.org/library/papers/40426572 | PubMed |
| 40246790 | A Systematic Review of Pharmacokinetic Studies of Colistin and Polymyxin B in Adult Populations. | Clin Pharmacokinet | 2025 | https://conductscience.org/library/papers/40246790 | PubMed |
| 40216659 | Meropenem-Vaborbactam for Treatment of Carbapenem-Resistant Enterobacterales: A Narrative Review of Clinical Practice Evidence. | Infect Dis Ther | 2025 | https://conductscience.org/library/papers/40216659 | PubMed |
| 39941468 | Colistin Use for the Treatment of Multi-Drug-Resistant Gram-Negative Severe Infections in ICU Patients: A Single-Center Study. | J Clin Med | 2025 | https://conductscience.org/library/papers/39941468 | PubMed |
| 39858357 | Cinnamic Acid Compounds (p-Coumaric, Ferulic, and p-Methoxycinnamic Acid) as Effective Antibacterial Agents Against Colistin-Resistant Acinetobacter baumannii. | Antibiotics (Basel) | 2025 | https://conductscience.org/library/papers/39858357 | PubMed |
| 39502715 | A Rapid and Simple HPLC-MS/MS Method for the Quantitative Determination of Colistin for Therapeutic Drug Monitoring in Clinical Practice. | Drug Des Devel Ther | 2024 | https://conductscience.org/library/papers/39502715 | PubMed |
| 39378315 | Innovative Microencapsulation of Polymyxin B for Enhanced Antimicrobial Efficacy via Coated Spray Drying. | Mol Pharm | 2025 | https://conductscience.org/library/papers/39378315 | PubMed |
| 39335037 | Focusing on the Basic Principles of Dialysis to Optimize Antibiotic Therapy during Renal Replacement Therapy in Critically Ill Patients. | Antibiotics (Basel) | 2024 | https://conductscience.org/library/papers/39335037 | PubMed |
| 39257909 | An overview of sulbactam-durlobactam approval and implications in advancing therapeutics for hospital-acquired and ventilator-associated pneumonia by acinetobacter baumannii-calcoaceticus complex: A narrative review. | Health Sci Rep | 2024 | https://conductscience.org/library/papers/39257909 | PubMed |
| 39065030 | Molecular Mechanisms of Bacterial Resistance to Antimicrobial Peptides in the Modern Era: An Updated Review. | Microorganisms | 2024 | https://conductscience.org/library/papers/39065030 | PubMed |
| 39050734 | Metabolomics highlights biochemical perturbations occurring in the kidney and liver of mice administered a human dose of colistin. | Front Mol Biosci | 2024 | https://conductscience.org/library/papers/39050734 | PubMed |
| 38931420 | Implementation of Modern Therapeutic Drug Monitoring and Lipidomics Approaches in Clinical Practice: A Case Study with Colistin Treatment. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/38931420 | PubMed |
| 38540175 | At the Intersection of Critical Care and Infectious Diseases: The Year in Review. | Biomedicines | 2024 | https://conductscience.org/library/papers/38540175 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| LDLR | 3949 | PubTator's text mining | https://conductscience.org/library/genes/3949 | NCBI Gene |
| LRP2 | 4036 | PubTator's text mining | https://conductscience.org/library/genes/4036 | NCBI Gene |
| SLC15A2 | 6565 | PubTator's text mining | https://conductscience.org/library/genes/6565 | NCBI Gene |
| SLC22A4 | 6583 | PubTator's text mining | https://conductscience.org/library/genes/6583 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36978303
GET https://conductscience.org/api/papers/v1/36978303/references?page=2